RMD News and Press, ResMed Inc.

2024-07-03 08:44:13 ET Summary RMD's competitive advantages in the sleep domain are durable, and its underlying business remains strong. It looks attractively valued based on future growth opportunities, resilient returns on capital, and potential for multiple expansions. A ma...

2024-06-29 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-25 13:37:45 ET More on Eli Lilly, ResMed, etc. Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End Eli Lilly And Alzheimer's Disease: The Paucity Of Progress Lilly gains appr...

2024-06-24 15:17:13 ET More on Inspire Medical, ResMed Inspire Medical Systems: A Post Q1 Assessment ResMed, Philips under pressure as Eli Lilly seeks sleep indication for weight loss drug Inspire Medical Systems, Inc. (INSP) Q1 2024 Earnings Call Transcript ...

2024-06-24 05:52:50 ET More on related stocks: Prudential: A Mispriced Growth Play In The Insurance Sector RXO, Inc.: Upgrade To Buy On Positive Volume And Pricing Outlook RXO, Inc. (RXO) Q1 2024 Earnings Call Transcript Freight M&A: UPS sells Coyote Logi...

2024-06-22 11:00:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: The Party Is Probably Nearing The End Novo Nordisk: Leading The Fight Against Diabetes And Obesity Eli Lilly And Alzheimer's Disease: The Paucity Of Progress ResMed, Philips under pressur...

2024-06-22 08:27:42 ET More on Eli Lilly, Philips, etc. Eli Lilly: The Party Is Probably Nearing The End Eli Lilly And Alzheimer's Disease: The Paucity Of Progress Eli Lilly: The Road To Approval Of Donanemab Is Open Lilly weight loss drug tirzepatide meets p...

2024-06-17 15:37:41 ET Summary For dividend growth investing, is growth more important than valuation? 49 stocks are valued based on Historical and Future Fair Valuations as well as analyst estimates. 49 stocks are further evaluated based on past dividend growth and future pro...

SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. He...

2024-06-08 06:50:00 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...